Skip to main content

Advertisement

SpringerLink
Log in

Update in Diagnosis and Treatment of Chronic Pelvic Pain Syndromes

  • Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

The diagnosis and treatment of chronic pelvic pain have shifted from organ-specific to multifactorial, multidisciplinary, and individualized approach. While many organizations have had diverse outlooks on classification and treatment plans, new research has identified varied clinical phenotypes and updated classification systems. These phenotypes are based on pain, gender, symptomatology, and comorbid pain syndromes. These new classification systems allow a multimodal therapeutic approach and evaluation of patients. Multidisciplinary care, including urology, gynecology, gastroenterology, neurology, psychology, physiotherapy, and pain medicine, is also further recognized for adequate management of patients with chronic pelvic pain because of its variable etiology. The purpose of this review is to emphasize these changes and discuss management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Nickel JC et al. Update on urologic pelvic pain syndromes. Rev Urol. 2011;13(1):39–49.

    PubMed Central  PubMed  Google Scholar 

  2. Hanno P et al. Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn. 2010;29(1):191–8.

    Article  PubMed  Google Scholar 

  3. Engeler DS et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64(3):431–9. Discussion of updated EAU guidelines on chronic pelvic pain, as well as description of UPOINT phenotyping classification symptom.

    Article  PubMed  Google Scholar 

  4. Clemens JQ et al. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol. 2014;14:57.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Shoskes DA et al. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis. 2009;12(2):177–83.

    Article  CAS  PubMed  Google Scholar 

  6. Nickel JC, Shoskes DA, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182(1):155–60.

    Article  PubMed  Google Scholar 

  7. Konkle KS et al. Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol. 2012;187(2):508–12.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Gamper M, et al. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol. 2015;193(6):1994–2000.

  9. Russell AL. Glycoaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn’s disease, interstitial cystitis and possibly Reiter’s syndrome. Med Hypotheses. 1999;52(4):297–301.

    Article  CAS  PubMed  Google Scholar 

  10. Logadottir Y et al. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis. Int J Urol. 2014;21 Suppl 1:75–8.

    Article  CAS  PubMed  Google Scholar 

  11. van de Merwe JP et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7.

    Article  PubMed  Google Scholar 

  12. Humphrey L et al. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score. Eur Urol. 2012;61(2):271–9.

    Article  PubMed  Google Scholar 

  13. Hanno PM et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.

    Article  PubMed  Google Scholar 

  14. Kuo YC, Kuo HC. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome. Int J Clin Pract. 2013;67(9):863–9.

    Article  PubMed  Google Scholar 

  15. Nickel JC, Tripp DA, G. International Interstitial Cystitis Study. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome. J Urol. 2015;193(1):138–44. This study identifies two major pain phenotypes in patients with IC/BPS and its association with somatic pain syndromes.

    Article  PubMed  Google Scholar 

  16. Nickel JC et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184(4):1358–63.

    Article  PubMed  Google Scholar 

  17. Krieger JN, et al. Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study. J Urol. 2014;193(4):1254–62. Baseline evaluation of the MAPP study which evaluates relationship between non-urological associated somatic syndromes and urologic chronic pelvic pain syndromes. Those with associated non-urological somatic syndromes had more severe urological symptoms and more frequent depression and anxiety.

  18. Bogart LM et al. Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis. Urology. 2011;77(3):576–80.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Kartha GK, Kerr H, Shoskes DA. Clinical phenotyping of urologic pain patients. Curr Opin Urol. 2013;23(6):560–4.

    Article  PubMed  Google Scholar 

  20. Hanno PM, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA Guideline Amendment. J Urol. 2015;193(5):1545–53. Amendment to the 2011 AUA Guidelines for diagnosis and treatment of IC/BPS.

  21. Nickel JC et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 2012;4(143):1–11.

    Article  Google Scholar 

  22. FitzGerald MP et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Pinto R et al. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis. J Urol. 2013;189(2):548–53.

    Article  CAS  PubMed  Google Scholar 

  24. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU. 2004;93:777–9.

    Article  CAS  Google Scholar 

  25. Wein A. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain editorial comment. J Urol. 2010;183(2):570.

    Article  Google Scholar 

  26. Whitmore K. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol. 2002;4(1):S28–35.

    PubMed Central  PubMed  Google Scholar 

  27. O'Hare 3rd PG et al. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J. 2013;24(6):977–82.

    Article  PubMed  Google Scholar 

  28. Chuang YC et al. Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study. Int Urol Nephrol. 2015;47(2):275–81.

    Article  PubMed  Google Scholar 

  29. Krsmanovic A et al. Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Can Urol Assoc J. 2014;8(11-12):403–8.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Nickel JC et al. Phenotype-directed management of interstitial cystitis/bladder pain syndrome. Urology. 2014;84(1):175–9.

    Article  PubMed  Google Scholar 

  31. Krieger J, Nyberg Jr L, Nickel C. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(2):236–7.

    Article  CAS  PubMed  Google Scholar 

  32. Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, et al. Management of chronic prostatitis/chronic pelvic pain syndrome. JAMA. 2011;305(1):78–86.

    Article  CAS  PubMed  Google Scholar 

  33. Rees J, Abrahams M, Doble A, Cooper A. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015(February 24). doi:10.1111/bju.13101 .

  34. Shoskes DA, Nickel JC. Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol. 2013;31(4):755–60. This study describes the UPOINT classification system within the realms of chronic prostatitis/chronic pelvic pain syndrome.

    Article  CAS  PubMed  Google Scholar 

  35. Wagenlehner FM et al. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013;63(5):953–9.

    Article  PubMed  Google Scholar 

  36. Nickel JC et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176(1):119–24.

    Article  PubMed  Google Scholar 

  37. Galley HF et al. Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med. 1997;25(8):1392–5.

    Article  CAS  PubMed  Google Scholar 

  38. Katsuno G et al. The immunosuppressive effects of ciprofloxacin during human mixed lymphocyte reaction. Clin Immunol. 2006;119(1):110–9.

    Article  CAS  PubMed  Google Scholar 

  39. Nickel JC et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003;169(4):1401–5.

    Article  CAS  PubMed  Google Scholar 

  40. Zhao WP et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Braz J Med Biol Res. 2009;42(10):963–7.

    Article  CAS  PubMed  Google Scholar 

  41. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. 2004;171(1):284–8.

    Article  PubMed  Google Scholar 

  42. Leskinen M, Lukkarinen O, Marttila T. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology. 1999;53(3):502–5.

    Article  CAS  PubMed  Google Scholar 

  43. Nickel JC et al. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. J Urol. 2011;186(4):1313–8.

    Article  CAS  PubMed  Google Scholar 

  44. Grimsley SJ, Khan MH, Jones GE. Mechanism of phosphodiesterase 5 inhibitor relief of prostatitis symptoms. Med Hypotheses. 2007;69(1):25–6.

    Article  CAS  PubMed  Google Scholar 

  45. Herati AS, Moldwin RM. Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome. World J Urol. 2013;31(4):761–6.

    Article  PubMed  Google Scholar 

  46. Lee SH, Lee BC. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology. 2009;73(5):1036–41.

    Article  PubMed  Google Scholar 

  47. Posadzki P et al. Acupuncture for chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a systematic review. J Androl. 2012;33(1):15–21.

    Article  PubMed  Google Scholar 

  48. Khorasani B et al. Transabdominal ultrasound measurement of pelvic floor muscle mobility in men with and without chronic prostatitis/chronic pelvic pain syndrome. Urology. 2012;80(3):673–7.

    Article  PubMed  Google Scholar 

  49. Clemens JQ et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 2000;56(6):951–5.

    Article  CAS  PubMed  Google Scholar 

  50. Cornel EB et al. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol. 2005;47(5):607–11.

    Article  PubMed  Google Scholar 

  51. Fitzgerald MP et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189(1 Suppl):S75–85.

    Article  PubMed  Google Scholar 

  52. Riegel B et al. Assessing psychological factors, social aspects and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men—a systematic review. J Psychosom Res. 2014;77(5):333–50.

    Article  PubMed  Google Scholar 

  53. Nickel JC, et al. Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP Research Network. J Urol. 2015;194(1):127–35. This article determined feasibility of a randomized clinical trial of manual therapy techniques and showed excellent therapist adherence and high global response assessment rate for the myofascial physical therapy group.

  54. Quick ML et al. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol. 2012;303(6):R580–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Wong L et al. Experimental autoimmune prostatitis induces microglial activation in the spinal cord. Prostate. 2015;75(1):50–9.

    Article  CAS  PubMed  Google Scholar 

  56. Tu FF, As-Sanie S, Steege JF. Prevalence of pelvic musculoskeletal disorders in a female chronic pelvic pain clinic. J Reprod Med. 2006;51(3):185–9.

    PubMed  Google Scholar 

  57. Bassaly R et al. Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis. Int Urogynecol J. 2011;22(4):413–8.

    Article  PubMed  Google Scholar 

  58. Bennett R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2007;21(3):427–45.

    Article  PubMed  Google Scholar 

  59. Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002;65(4):653–60.

    PubMed  Google Scholar 

  60. Gyang A, Hartman M, Lamvu G. Musculoskeletal causes of chronic pelvic pain: what a gynecologist should know. Obstet Gynecol. 2013;121(3):645–50.

    Article  PubMed  Google Scholar 

  61. Prendergast SA, Weiss JM. Screening for musculoskeletal causes of pelvic pain. Clin Obstet Gynecol. 2003;46(4):773–82.

    Article  PubMed  Google Scholar 

  62. Cummings M, Baldry P. Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol. 2007;21(2):367–87.

    Article  PubMed  Google Scholar 

  63. Curatolo M, Arendt-Nielsen L, Petersen-Felix S. Evidence, mechanisms, and clinical implications of central hypersensitivity in chronic pain after whiplash injury. Clin J Pain. 2004;20(6):469–76.

    Article  PubMed  Google Scholar 

  64. FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. I: background and patient evaluation. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(4):261–8.

    Article  CAS  PubMed  Google Scholar 

  65. Simons DG, Travell J. Myofascial trigger points, a possible explanation. Pain. 1981;10(1):106–9.

    Article  CAS  PubMed  Google Scholar 

  66. McPartland JM. Travell trigger points—molecular and osteopathic perspectives. J Am Osteopath Assoc. 2004;104(6):244–9.

    PubMed  Google Scholar 

  67. Dhingra C et al. Urogynecological causes of pain and the effect of pain on sexual function in women. Female Pelvic Med Reconstr Surg. 2012;18(5):259–67.

    Article  PubMed  Google Scholar 

  68. Crisp CC et al. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24(11):1915–23.

    Article  PubMed  Google Scholar 

  69. Adelowo A et al. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Female Pelvic Med Reconstr Surg. 2013;19(5):288–92.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Abbott JA et al. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.

    Article  PubMed  Google Scholar 

  71. Thomson AJ et al. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG. 2005;112(2):247–9.

    Article  PubMed  Google Scholar 

  72. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med. 2004;49(10):772–7.

    PubMed  Google Scholar 

  73. Ventolini G. Vulvar pain: anatomic and recent pathophysiologic considerations. Clin Anat. 2013;26(1):130–3.

    Article  PubMed  Google Scholar 

  74. Reed BD et al. Factors associated with vulvodynia incidence. Obstet Gynecol. 2014;123(2 Pt 1):225–31.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Leo RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(8):2000–8.

    Article  PubMed  Google Scholar 

  76. Reed BD et al. Relationship between vulvodynia and chronic comorbid pain conditions. Obstet Gynecol. 2012;120(1):145–51.

    Article  PubMed Central  PubMed  Google Scholar 

  77. Hampson JP et al. Augmented central pain processing in vulvodynia. J Pain. 2013;14(6):579–89. This article describes central pain processing in patients with vulvodynia via MRI.

    Article  PubMed Central  PubMed  Google Scholar 

  78. De Andres J, et al. Vulvodynia—an evidence-based literature review and proposed treatment algorithm. Pain Pract. 2015. doi:10.1111/papr.12274.

  79. Ventolini G et al. Vulvodynia and fungal association: a preliminary report. Med Hypotheses. 2013;81(2):228–30.

    Article  CAS  PubMed  Google Scholar 

  80. Reed BD et al. Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG. 2013;120(13):1678–84.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Bouchard C. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol. 2002;156(3):254–61.

    Article  PubMed  Google Scholar 

  82. Pagano R, Wong S. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. J Lower Genital Tract Dis. 2012;16(4):394–7.

    Article  Google Scholar 

  83. Zolnoun D. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102(1):84–7.

    Article  CAS  PubMed  Google Scholar 

  84. Steinberg AC et al. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol. 2005;192(5):1549–53.

    Article  CAS  PubMed  Google Scholar 

  85. McDonald JS, Rapkin AJ. Multilevel local anesthetic nerve blockade for the treatment of generalized vulvodynia: a pilot study. J Sex Med. 2012;9(11):2919–26.

    Article  PubMed  Google Scholar 

  86. Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. Int Urogynecol J. 2010;21(12):1553–8.

    Article  PubMed  Google Scholar 

  87. Ramsay LB, Wright Jr J, Fischer JR. Sacral neuromodulation in the treatment of vulvar vestibulitis syndrome. Obstet Gynecol. 2009;114:487–9.

    Article  PubMed  Google Scholar 

  88. De Andres J et al. Peripheral subcutaneous vulvar stimulation in the management of severe and refractory vulvodynia. Obstet Gynecol. 2013;121(2):495–8.

    PubMed  Google Scholar 

  89. Schlaeger JM, et al. Acupuncture for the treatment of vulvodynia: a randomized wait-list controlled pilot study. J Sex Med. 2015;12(4):1019–27.

  90. Heddini U et al. Provoked vestibulodynia—medical factors and comorbidity associated with treatment outcome. J Sex Med. 2012;9(5):1400–6.

    Article  PubMed  Google Scholar 

  91. Liu B et al. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. Urology. 2014;84(6):1308–13.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Nima Shah, Natasha Ginzburg, Darlene Morrissey, and Kristene Whitmore declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Drexel University College of Medicine, 207 North Broad St, 4th floor, Philadelphia, PA, 19107, USA

    Nima Shah, Natasha Ginzburg & Darlene Morrissey

  2. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Drexel University College of Medicine, Pelvic and Sexual Health Institute, 207 North Broad St, 4th floor, Philadelphia, PA, 19107, USA

    Kristene Whitmore

Authors
  1. Nima Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Natasha Ginzburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Darlene Morrissey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kristene Whitmore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristene Whitmore.

Additional information

This article is part of the Topical Collection on Inflammatory/Infectious Bladder Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, N., Ginzburg, N., Morrissey, D. et al. Update in Diagnosis and Treatment of Chronic Pelvic Pain Syndromes. Curr Bladder Dysfunct Rep 10, 198–206 (2015). https://doi.org/10.1007/s11884-015-0302-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-015-0302-y

Keywords

Search

Navigation